Wells Fargo Maintains Overweight on Tenet (THC) Feb 2026, PT $265
THC analyst rating: Wells Fargo maintained an Overweight rating on Tenet Healthcare Corporation (THC) and raised its price target to $265 on Feb 16, 2026. This action kept the firm’s positive stance while increasing modeled upside from $229. The move follows Tenet’s Q4 2025 results and 2026 adjusted EBITDA guidance. Meyka AI rates THC with a grade of A, reflecting S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These notes are for information and not financial advice.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
